Literature DB >> 3351612

Recommended method for indium-111 platelet survival studies. International Committee for Standardization in Hematology. Panel on Diagnostic Applications of Radionuclides.

.   

Abstract

Radioactive indium (111In) has been introduced as an alternative to 51Cr as a platelet label because of its shorter half-life, higher photon yield and greater affinity for platelets. Furthermore, platelet labelling with 111In is possible at lower platelet counts than with 51Cr. In healthy individuals, the kinetics of simultaneously injected 111In-labeled and 51Cr-labeled platelets are similar. The document describes the technical and analytic aspects of platelet survival determination with 111In-labeled platelets and is intended to supplement the previously published recommendations for platelet survival studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3351612

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

Review 1.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

2.  Platelet labelling with indium-hydroxypyridinone and indium-hydroxypyranone complexes.

Authors:  R D Abeysinghe; B L Ellis; J B Porter
Journal:  Eur J Nucl Med       Date:  1994-10

3.  Anti-glycoprotein antibodies and sequestration pattern of indium-labeled platelets in immune thrombocytopenia.

Authors:  Sufia N Amini; Leendert Porcelijn; Annemieke Sobels; Marina Kartachova; Masja de Haas; Jaap Jan Zwaginga; Martin R Schipperus
Journal:  Blood Adv       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.